Type-2 diabetes risk lowered by lorcaserin in people who have cardiovascular disease or obesity

Lorcaserin lowers the risk of adults with obesity or cardiovascular disease developing type-2 diabetes, according to research presented at European Association for the Study of Diabetes meeting.Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news